KindlyMD Board approves $500,000 stock repurchase program

Nakamoto Inc.

Board authorized repurchase of up to $500,000 in common stock, effective Oct 15, 2024.
Repurchases may be made in open market or private transactions at management's discretion.
Program has no time limit and may be suspended or discontinued at any time; no obligation to repurchase any shares.
CEO Tim Pickett says buyback demonstrates confidence in valuation and commitment to shareholder value.
Company will engage a broker-dealer and comply with Rule 10b-18 safe harbor requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.